Irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) are highly prevalent gastrointestinal disorders associated with health, economical and social problems. Recently, after a long journey of preclinical studies and clinical trials, linaclotide, a first-in-class GC-C receptor peptide agonist, has received the approval in the USA and Europe for the treatment of IBS-C and CIC. This article provides an overview of clinical, economic and biological aspects of IBS-C and CIC and covers the current and emerging therapeutic agents for treating these conditions. Particularly, the pharmacodynamic and pharmacokinetic properties of linaclotide, a small, disulfide-rich peptide, and its implications in the future of peptide drug discovery and development are discussed.

Download full-text PDF

Source
http://dx.doi.org/10.4155/fmc.13.5DOI Listing

Publication Analysis

Top Keywords

long journey
8
implications future
8
future peptide
8
ibs-c cic
8
peptide
5
constella™eu-linzess™usa milestone
4
milestone long
4
journey peptide
4
peptide linaclotide
4
linaclotide implications
4

Similar Publications

Background: Stillbirth occurs at a rate of 3.0 per thousand in Sweden. However, few studies have focused on the initial experiences of parents facing a stillbirth.

View Article and Find Full Text PDF

Parenthood inevitably includes caring for a child suffering from mild-moderate illness requiring access to health care. Most childhood illnesses can be managed in the community, and parents are encouraged to attend the most suitable primary care service for their needs. Yet the number of children visiting emergency departments with non-urgent illness continues to rise annually, with child attendance representing over 25% of the total workload.

View Article and Find Full Text PDF

The Instagram account (@Balance_ton_bar) highlighted the issue of sexual violence in Brussels nightlife sharing testimonials from victim-survivors. Set up in response to reports of drug-facilitated sexual assault at nightlife establishments, the account aimed to raise awareness and hold establishments accountable. This study examines these testimonials to explore how violence was perpetrated-through chemical drugging, alcohol use, isolation, and social power-the socio-emotional consequences for victim-survivors, and their journeys in seeking support.

View Article and Find Full Text PDF

Sexual Health in Women and Sexual-Gender-Minority Patients with Cancer: A Nationwide Survey on Healthcare Professional Awareness and Attitude on behalf of MITO and AIRO-Gynecology Group.

J Cancer Policy

December 2024

Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy; Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, Foundation IRCCS Polyclinic San Matteo, Pavia, Italy.

Background: Compared to male patients, sexual health remains poorly studied in women and sexual gender minority (SGM) patients with cancers.

Material And Methods: An online survey was developed by a multidisciplinary team to assess the awareness and attitude of Italian oncological providers facing sexual health during or after cancer treatment. On behalf of the respective scientific committees, the questionnaire was sent to Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies group (MITO) and to Italian Association of Radiation Oncology (AIRO) Group.

View Article and Find Full Text PDF

The journey to becoming a plastic surgeon is a long one. Most nonsurgeons are unaware of the actual scope of plastic surgery and the spectrum of surgeries done by plastic surgeons. The constant look-out for "cutting chances" from early in the career can be quite exhausting and may take a toll on the professional relationships as well as personal lives of plastic surgeons.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!